Nadler Financial Group, Inc. Edwards Lifesciences Corp Transaction History

Nadler Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$72.54 - $95.56 $170,904 - $225,139	2,356 New	2,356 $225,000
Q2 2022 Jul 20, 2022	SELL	$86.5 - $128.27 $6,314 - $9,363	-73 Reduced 3.01%	2,356 $224,000
Q1 2022 May 05, 2022	SELL	$101.96 - $128.34 $53,732 - $67,635	-527 Reduced 17.83%	2,429 $286,000
Q2 2021 Jul 16, 2021	SELL	$83.84 - $104.76 $30,182 - $37,713	-360 Reduced 10.86%	2,956 $306,000
Q1 2021 Apr 14, 2021	BUY	$78.68 - $90.67 $5,822 - $6,709	74 Added 2.28%	3,316 $277,000
Q4 2020 Jan 26, 2021	BUY	$71.69 - $91.23 $8,244 - $10,491	115 Added 3.68%	3,242 $296,000
Q3 2020 Oct 07, 2020	BUY	$67.19 - $87.44 $335 - $437	5 Added 0.16%	3,127 $250,000
Q2 2020 Jul 09, 2020	BUY	$57.54 - $76.95 $179,639 - $240,237	3,122 New	3,122 $216,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Nadler Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Nadler Financial Group, Inc. with notifications on news.